gvtcx

supplier

Celltrion Healthcare United Kingdom Limited

SL11QP combined from 2 published records

Celltrion Healthcare United Kingdom Limited has won 44 UK public sector awards from 8 buyers since 2020. The typical award is worth £480,429,000.

as a supplier

44 recorded awards from 8 buyers , between 15 Jan 2020 and 26 Nov 2025.

awards won
44
exclusive
0%
0 sole-winner awards
median award
£480.4m
largest
£986.3m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

contracts won

contractbuyervalueawarded
NHS National Framework Agreement for Omalizumab shared NHS England £87,433,000 26 Nov 2025
NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 shared NHS England £986,282,758 30 Jun 2025
CM/TNS/24/5711 -NHS Framework for the supply of Ustekinumab shared NHS England £230,000,000 12 Aug 2024
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche shared NHS England £480,429,000 13 Feb 2023
NHS Framework for North of England Branded Medicines Tranche A & Annual Tranche shared NHS England £261,970,000 8 Feb 2023
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual shared NHS England £216,078,796 7 Feb 2022
NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche shared NHS England £203,608,551 11 Feb 2021
NHS Framework for the NHS London Region, Branded Medicines - Tranche A shared NHS England £191,062,951 16 Jun 2020
NHS Midlands and East Branded Medicines - Tranche A shared NHS England £418,787,000 15 Jan 2020
NHS National Framework Agreement for Omalizumab shared NHS England · 30 Dec 2025
Branded and Biosimilar Ophthalmology shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 24 Nov 2025
Medicinal Products and Pharma Funded Homecare [5749446] shared Regional Business Services Organisation Procurement and Logistics Service · 17 Jun 2025
Medicinal Products and Pharma Funded Homecare [5749446] shared Regional Business Services Organisation Procurement and Logistics Service · 17 Jun 2025
Biologic and Biosimilar Medicines shared eTenderwales · 21 May 2025
NP47924 Cytokine Modulators shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 19 Mar 2025
NP47924 Cytokine Modulators shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 19 Mar 2025
NP39724 Generic and Biosimilar Cancer Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 27 Feb 2025
Ustekinumab and Omalizumab shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 11 Sept 2024
Ustekinumab and Omalizumab shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 11 Sept 2024
NP47923a Adalimumab shared The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 7 Feb 2024
Generic and Biosimilar Cancer Medicines shared The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") · 21 Apr 2023
National Framework Agreement for Adalimumab Injection 1 April 2023 shared NHS England · 24 Mar 2023

every contract won by Celltrion Healthcare United Kingdom Limited →

as published

This page combines 2 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Celltrion Healthcare United Kingdom Limited · SL1 1QP 39
Celltrion Healthcare United Kingdom Ltd GB-COH 11685363 UB8 1JG 5

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works